Alcresta

Alnara

The company develops protein therapeutics to treat metabolic diseases, such as exocrine pancreatic insufficiency, for patients with conditions including cystic fibrosis and chronic pancreatitis.

Allena

This biopharmaceutical company develops oral enzyme therapeutics for patients with rare and severe metabolic and kidney disorders, such as hyperoxaluria.

Alcolase

This biotech company develops enzyme supplements for individuals with alcohol intolerance and ALDH2 deficiency to break down alcohol before it enters the bloodstream.

Alesta Therapeutics

This biotechnology company develops oral small molecule therapies for patients with rare genetic disorders including hypophosphatasia and Charcot-Marie-Tooth disease.

Allievex

This clinical-stage biotechnology company develops enzyme replacement therapies for children with rare pediatric neurodegenerative diseases, specifically Sanfilippo syndrome type B.

Spruce Biosciences

This biopharmaceutical company develops enzyme replacement therapies and small molecules for patients with rare endocrine and neurological disorders.

Enzymotec

This company develops and manufactures lipid-based biofunctional ingredients for nutritional and pharmaceutical firms specializing in infant, cardiovascular, and cognitive health.

Phenotap

This company develops enzymes for blood glucose and ketone monitoring device manufacturers to enable continuous metabolic tracking and diabetic ketoacidosis detection.